tiprankstipranks
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
PremiumThe FlyAnalyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
9d ago
DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls
PremiumThe Fly
DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls
9d ago
Vertex Pharmaceuticals price target raised to $462 from $457 at H.C. Wainwright
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $462 from $457 at H.C. Wainwright
9d ago
M&A: Vertex Bolsters its Drug Portfolio with Alpine Deal
PremiumMarket NewsM&A: Vertex Bolsters its Drug Portfolio with Alpine Deal
9d ago
Vertex to acquire Alpine Immune Sciences for $65 per share
PremiumThe Fly
Vertex to acquire Alpine Immune Sciences for $65 per share
9d ago
RBC says pain opinion leader ‘notably negative’ on Vertex’s VX-548
PremiumThe Fly
RBC says pain opinion leader ‘notably negative’ on Vertex’s VX-548
12d ago
Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
PremiumMarket NewsAre Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
19d ago
Truist pharmaceuticals analyst holds an analyst/industry conference call
PremiumThe Fly
Truist pharmaceuticals analyst holds an analyst/industry conference call
23d ago
Vertex Pharmaceuticals announces FDA clearance of VX-407 IND
PremiumThe Fly
Vertex Pharmaceuticals announces FDA clearance of VX-407 IND
30d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100